Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Risk Assessment of Long-Haul Truck Drivers

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT00381992
Recruitment Status : Completed
First Posted : September 28, 2006
Last Update Posted : November 7, 2017
Sponsor:
Collaborators:
National Institute of Mental Health (NIMH)
University of Alabama at Birmingham
Information provided by (Responsible Party):
Wake Forest University Health Sciences

Study Description
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information
Brief Summary:
International studies have repeatedly documented a substantial prevalence of sexual risk behaviors and high rates of human immunodeficiency virus (HIV) and other sexually transmitted infections (STI) ranging from 5%-56% amongst long-distance truck drivers ("truckers") living in diverse international settings including India, Bangladesh, South Africa, China, Laos and Thailand. The prevalence of sexual risk factors and STI/HIV in US drivers is unknown. This proposal will provide both qualitative and quantitative data on HIV risk behaviors by interviewing and testing truckers working for established long-distance trucking firms, the sector which accounts for most of the jobs in the trucking and warehousing industry in the United States. The data obtained from this study will be used to inform the development of an HIV prevention intervention for long-haul truck drivers.

Condition or disease
Gonorrhea Chlamydia Infections Hepatitis B Hepatitis C Diabetes Mellitus Hypertension Obesity HIV Infections Hyperlipidemia

Detailed Description:

The study proposed in this R34 application will address the following specific aims:

Specific Aim 1. To perform focus groups and in-depth interviews with long-haul truck drivers to guide development of both a behavioral risk assessment instrument and an acceptable HIV/STI screening protocol for long-haul truckers.

Specific Aim 2. To perform in-depth interviews with trucking industry executives to determine barriers to routine HIV/STI assessment and screening of their employees.

Specific Aim 3. To perform a pilot phase with a subsample of long-haul truck drivers characterized by the following steps: TTM-based "cognitive interviews" (N=5); pilot testing of the survey and biomedical screening protocol (N=15); and a follow-up focus group (N=8)

Specific Aim 4. To assess a sample of (N=300) truck drivers for general health and sexual risk behaviors using the adapted theory-based survey and to determine the prevalence of hepatitis B, hepatitis C, hypertension, hyperlipidemia, diabetes and obesity, HIV, N. gonorrhoeae, and C. trachomatis

Study Design
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Layout table for study information
Study Type : Observational
Actual Enrollment : 294 participants
Observational Model: Other
Time Perspective: Cross-Sectional
Official Title: Risk Assessment of Long-Haul Truck Drivers
Study Start Date : September 2005
Actual Primary Completion Date : March 2010
Actual Study Completion Date : March 2010

Resource links provided by the National Library of Medicine

MedlinePlus related topics: HIV/AIDS

Groups and Cohorts
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information


Outcome Measures
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Primary Outcome Measures :
  1. The prevalence of hepatitis B, hepatitis C, hypertension, hyperlipidemia, diabetes and obesity, HIV, N. gonorrhoeae, and C. trachomatis [ Time Frame: Cross-sectional ]

Eligibility Criteria
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   21 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
American long-haul truck drivers affiliated with participating companies or presenting as clients at participating truck stops.
Criteria

Inclusion Criteria:

  1. Long-haul truck driver as defined as a driver, part-time or full-time, who drives a truck across state lines (interstate)
  2. English speaking
  3. Age 21 or greater
  4. Willing to participate
  5. Able to provide written informed consent

Exclusion Criteria:

  1. Does not fit definition of truck driver in inclusion criteria #1
  2. Unwilling to participate
  3. Unwilling or unable to provide informed consent
  4. Unable to understand or speak English
  5. Age < 21 years
Contacts and Locations
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00381992


Locations
Layout table for location information
United States, North Carolina
Wake Forest University Health Sciences
Winston-Salem, North Carolina, United States, 27157
Sponsors and Collaborators
Wake Forest University Health Sciences
National Institute of Mental Health (NIMH)
University of Alabama at Birmingham
Investigators
Layout table for investigator information
Principal Investigator: Laura H Bachmann, MD, MPH Wake Forest University Health Sciences
More Information
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information
Publications of Results:

Layout table for additonal information
Responsible Party: Wake Forest University Health Sciences
ClinicalTrials.gov Identifier: NCT00381992    
Other Study ID Numbers: F060815005
5R34MH073411-03 ( U.S. NIH Grant/Contract )
First Posted: September 28, 2006    Key Record Dates
Last Update Posted: November 7, 2017
Last Verified: December 2014
Keywords provided by Wake Forest University Health Sciences:
sexual risk behavior
diabetes mellitus
hypertension
obesity
 human immunodeficiency virus
hyperlipidemia
chlamydia
Additional relevant MeSH terms:
Layout table for MeSH terms
Infection
Communicable Diseases
Chlamydia Infections
Gonorrhea
Hepatitis A
Hepatitis C
Hepatitis B
Hepatitis
Hypertension
Diabetes Mellitus
Hyperlipidemias
Hyperlipoproteinemias
Glucose Metabolism Disorders
Metabolic Diseases
Endocrine System Diseases
 Vascular Diseases
Cardiovascular Diseases
Liver Diseases
Digestive System Diseases
Hepatitis, Viral, Human
Virus Diseases
Enterovirus Infections
Picornaviridae Infections
RNA Virus Infections
Flaviviridae Infections
Sexually Transmitted Diseases
Hepadnaviridae Infections
DNA Virus Infections
Dyslipidemias
Lipid Metabolism Disorders